Stay updated on Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new site revision entry (v3.5.4) was added and the previous revision (v3.5.3) removed in the record history, signaling a platform update to the ClinicalTrials.gov interface.
    Difference
    0.1%
    Check dated 2026-05-14T23:17:09.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The Record History page shows a new revision tag: v3.5.3 is now listed, replacing the previous v3.5.2, indicating a minor version update to the page’s history data.
    Difference
    0.1%
    Check dated 2026-04-30T17:31:45.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 replaces the previous version v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T11:11:36.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated with a new Revision v3.5.0 and removal of Revision v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:43.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:52:49.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The previous notices about government funding and operating status were removed.
    Difference
    0.6%
    Check dated 2026-02-11T02:23:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab SubQ vs IV in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab SubQ vs IV in Melanoma Clinical Trial page.